Mode
Text Size
Log in / Sign up
N/A N=15 Randomized Double-blind Treatment

Impact of Pillboxes on Medical Adherence

Chronic Disease · Medication Adherence

Enrolled (actual)
15
Serious AEs
0.0%
Results posted
Aug 2020
Primary outcome: Primary: Medication Adherence at 1 Month — 11.83; 10.20; 9.33 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Standard off-the-shelf pillbox (Device); Custom off-the-shelf pillbox (Device); Custom designed and manufactured pillbox (Device); Education & Training (Behavioral); Reflection on medication routines (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Florida International University
Primary completion
May 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Medication Adherence at 1 Month
11.83; 10.20; 9.33
PRIMARY
Satisfaction With Pillbox at 1 Month
4.65; 4.63; 4.72
SECONDARY
Number of Participants Who Completed the Study
6; 5; 4

Summary

This study uses an experimental design to test the impact of different types of pillboxes on medication adherence. Participants in this study will randomized to receive one of the three pillbox interventions: 1) A standard seven day a week, one-dose per day pillbox with training 2) an off-the-shelf pillbox that was purchased specifically for the individual's needs with training and education, or 3) a customized 3D printed pillbox that was designed and manufactured specifically to the individual's needs with training and education. Participants will have three visits with the research team to collect baseline data, receive the pillbox, and collect follow up data. Risks to the study include loss of time, boredom, invasion of privacy, and medication errors. The investigators have taken precautions to mitigate these risks. This study will improve understanding of medication adherence and potentially help us better address poor medication adherence which needlessly causes morbidity, mortality, and costs over $300 million in unnecessary healthcare costs each year.

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • speak English
  • be prescribed to take two or more medications per day, and manage their own medications.

Exclusion Criteria

  • have a significant cognitive impairment
  • unwilling to use a novel pillbox
  • unable to meet with the research team
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03861845). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search